is tirzepatide going off the market A Major GLP-1 Drug Shortage Over. Some Patients Aren't Celebrating The FDA says the Zepbound

A 2024 meta-analysis confirmed that subcutaneous semaglutide showed greater effectiveness for weight reduction, and that patients on oral semaglutide had a significantly higher rate of discontinuation due to side effects

RELATED: Is compounded semaglutide safe

I have lost 40 pounds, my A1C has gone from 7.1 to 5.5, and none of my clothes fit

Este fue un estudio aleatorizado, doble ciego, controlado con placebo, de 64 semanas de duracin, que evalu semaglutida oral 25 mg una vez al da versus placebo en 307 adultos con obesidad (IMC 30 kg/m) o sobrepeso (IMC 27 kg/m) con al menos una comorbilidad relacionada con el peso, sin diabetes

This is where trained health-care providers are a really important conversation because these medications are long term

Zheng, H., Jiang, L., Tsuduki, T., Conrad, M